Literature DB >> 27522065

Hepatitis E virus infection in the Irish blood donor population.

Joan O'Riordan1, Fiona Boland1, Padraig Williams1, Joe Donnellan1, Boris M Hogema2, Samreen Ijaz3, William G Murphy1.   

Abstract

BACKGROUND: Hepatitis E virus (HEV) Genotype 3 (G3) infection is a zoonosis that may be transmitted during the acute phase by transfusion. The aim of this study was to determine the incidence of HEV and seroprevalence among Irish blood donors. STUDY DESIGN AND METHODS: Anonymized samples from 1076 donations collected in 2012 were tested for HEV immunoglobulin (Ig)G using the Wantai enzyme-linked immunosorbent assay. A total of 24,985 anonymized donations collected between December 2013 and June 2014 were individually tested for HEV RNA using the Procleix HEV assay; reactive donations were confirmed by an in-house real-time polymerase chain reaction (PCR) test.
RESULTS: Seroprevalence for anti-IgG was 5.3% (95% confidence interval [CI], 4.0%-6.8%), ranging from 1.1% in the 18- to 29-years age group to 33.3% in males over 60 years. HEV RNA screening of 24,985 samples yielded five PCR-confirmed donations (1:4997, 0.02%; 95% CI, 0.0065%-0.0467%), only one of which was serologically reactive (HEV IgM reactive only). Viral loads ranged from 10 to 44,550 IU/mL. Genotype analysis on three samples identified HEV G3 virus. Four of the five viremic donations were from donors in the 18- to 29-years age group (p = 0.01).
CONCLUSION: Seroprevalence for anti-HEV IgG was low compared to some European countries, but 1 in 5000 donations was viremic. Viremia was predominantly in younger Irish donors. After Department of Health approval the Irish Blood Transfusion Service implemented individual blood donation HEV RNA screening initially for a 3-year period from January 2016.
© 2016 AABB.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27522065     DOI: 10.1111/trf.13757

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  20 in total

1.  Early hepatitis E infection in an unrelated hematopoietic progenitor stem cell donor.

Authors:  D O'Donghaile; N O'Flaherty; S Field
Journal:  Bone Marrow Transplant       Date:  2017-07-17       Impact factor: 5.483

Review 2.  Blood Donor Screening for Hepatitis E Virus in the European Union.

Authors:  Fiona Boland; Auxiliadora Martinez; Louise Pomeroy; Niamh O'Flaherty
Journal:  Transfus Med Hemother       Date:  2019-03-14       Impact factor: 3.747

3.  Hepatitis E in a Portuguese cohort of human immunodeficiency virus positive patients: High seroprevalence but no chronic infections.

Authors:  Rita Filipe; Beatriz Prista-Leão; André Silva-Pinto; Isabel Abreu; Rosário Serrão; Rosário Costa; Edite Guedes; Joana Sobrinho-Simões; António Sarmento; Carmo Koch; Lurdes Santos
Journal:  Health Sci Rep       Date:  2022-05-20

4.  A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors.

Authors:  Enea Spada; Simonetta Pupella; Giulio Pisani; Roberto Bruni; Paola Chionne; Elisabetta Madonna; Umbertina Villano; Matteo Simeoni; Sara Fabi; Giuseppe Marano; Cinzia Marcantonio; Patrizio Pezzotti; Anna R Ciccaglione; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-05-04       Impact factor: 3.443

Review 5.  Hepatitis E Virus in Industrialized Countries: The Silent Threat.

Authors:  Pilar Clemente-Casares; Carlota Ramos-Romero; Eugenio Ramirez-Gonzalez; Antonio Mas
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

6.  Hepatitis E and blood donation safety in selected European countries: a shift to screening?

Authors:  Dragoslav Domanović; Richard Tedder; Johannes Blümel; Hans Zaaijer; Pierre Gallian; Christoph Niederhauser; Silvia Sauleda Oliveras; Joan O'Riordan; Fiona Boland; Lene Harritshøj; Maria São José Nascimento; Anna Rita Ciccaglione; Constatina Politis; Cornelia Adlhoch; Benoit Flan; Wahiba Oualikene-Gonin; Guy Rautmann; Paul Strengers; Patricia Hewitt
Journal:  Euro Surveill       Date:  2017-04-20

Review 7.  Hepatitis E in High-Income Countries: What Do We Know? And What Are the Knowledge Gaps?

Authors:  Lisandru Capai; Rémi Charrel; Alessandra Falchi
Journal:  Viruses       Date:  2018-05-25       Impact factor: 5.048

8.  Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.

Authors:  Jens Dreier; Cornelius Knabbe; Tanja Vollmer
Journal:  Front Med (Lausanne)       Date:  2018-02-01

9.  Hepatitis E virus (HEV) in Scotland: evidence of recent increase in viral circulation in humans.

Authors:  Katrina Thom; Pamela Gilhooly; Karen McGowan; Kristen Malloy; Lisa M Jarvis; Claire Crossan; Linda Scobie; Oliver Blatchford; Alison Smith-Palmer; Mhairi C Donnelly; Janice S Davidson; Ingolfur Johannessen; Kenneth J Simpson; Harry R Dalton; Juraj Petrik
Journal:  Euro Surveill       Date:  2018-03

10.  Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries.

Authors:  Evan M Bloch; Ruchika Goel; Silvano Wendel; Thierry Burnouf; Arwa Z Al-Riyami; Ai Leen Ang; Vincenzo DeAngelis; Larry J Dumont; Kevin Land; Cheuk-Kwong Lee; Adaeze Oreh; Gopal Patidar; Steven L Spitalnik; Marion Vermeulen; Salwa Hindawi; Karin Van den Berg; Pierre Tiberghien; Hans Vrielink; Pampee Young; Dana Devine; Cynthia So-Osman
Journal:  Vox Sang       Date:  2020-07-20       Impact factor: 2.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.